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Excitotoxicity is a major component of neurodegenerative diseases and is typically
accompanied by an inflammatory response. Cytokines IL-1alpha and IL-1beta are key
regulators of this inflammatory response and modulate the activity of numerous cell
types, including neurons. IL-1RAcPb is an isoform of IL-1RAcP expressed specifically in
neurons and promotes their survival during acute inflammation. Here, we investigated
in vivo whether IL-1RAcPb also promotes neuronal survival in a model of excitotoxicity.
Intrastriatal injection of kainic acid (KA) in mice caused a strong induction of IL-1 cytokines
mRNA in the brain. The stress response of cortical neurons at 12 h post-injection, as
measured by expression of Atf3, FoxO3a, and Bdnf mRNAs, was similar in WT and
AcPb-deficient mice. Importantly however, a delayed upregulation in the transcription of
calpastatin was significantly higher in WT than in AcPb-deficient mice. Finally, although
absence of AcPb signaling had no effect on damage to neurons in the cortex at early
time points, it significantly impaired their long-term survival. These data suggest that in a
context of excitotoxicity, stimulation of IL-1RAcPb signaling may promote the activity of a
key neuroprotective mechanism.
Keywords: interleukin-1, IL-1RAcPb, excitotoxicity, neuronal death, kainic acid, calcium, calpastatin, brain-derived
neurotrophic factor
INTRODUCTION
Neuronal dysfunctions and damage associated with excitotoxic
insults are intrinsically linked with aberrant calcium signaling
in neurons and are implicated in a wide variety of neurode-
generative diseases, including strokes, epilepsy and Alzheimer’s
disease. Shortly after the initiation of these insults, an inflamma-
tory response driven by microglia and astrocytes is triggered to
promote the re-establishment of neuronal homeostasis and func-
tions. Members of the interleukin 1 family of cytokines, including
IL-1α and IL-1β, are among the most important and pleiotropic
regulators of the inflammatory response associated with excito-
toxic insults. Binding of either cytokines to the IL-1 receptor type
1 (IL-1R1) causes its heterodimerization with IL-1 receptor acces-
sory protein (IL-1RAcP, or AcP) (Korherr et al., 1997; Cullinan
et al., 1998). This complex then recruits adaptor protein MyD88,
which then allows for the activation of signaling pathways that
regulate the activity of MAP kinases and NF-κB transcription
factors (Muzio et al., 1997; Medzhitov et al., 1998).
A strong body of evidence suggests that IL-1 signaling
enhances neuronal damage in a context of excitotoxicity (Relton
and Rothwell, 1992; Vezzani et al., 2000; Viviani et al., 2003;
Bender and Baram, 2007; Andoh et al., 2008; Kwon et al., 2010;
Zheng et al., 2010; Maroso et al., 2011). Indeed, IL-1β poten-
tiated NMDA-induced increase in intracellular calcium and led
to an exacerbation of neuronal cell death in vitro (Viviani et al.,
2003). In mice, inhibition of IL-1β by intrastriatal injection of
recombinant IL-1 receptor antagonist (IL-1RA), an endogenous
antagonist of IL-1β, protected neurons from the excitotoxic effects
of a NMDA receptor agonist injection (Relton and Rothwell,
1992). Similar effects were noted in transgenic mice engineered to
overexpress high levels of the human IL-RA in the brain (Vezzani
et al., 2000). Finally, IL-1β synthesis also correlated with increased
neuronal death and increased seizure activity (Kwon et al., 2010;
Maroso et al., 2011). Therefore, with respect to excitotoxic insults,
IL-1 signaling appears to increase neuronal dysfunctions and
death.
In contrast, others have reported a protective role for IL-1
cytokines during excitotoxicity (Ohtsuki et al., 1996; Carlson
et al., 1999; Bernardino et al., 2005; Durukan and Tatlisumak,
2010; Hayakawa et al., 2010; Wang et al., 2010; Mayado et al.,
2011). For instance, IL-1α and IL-1β both increased survival
of neurons stimulated by prolonged exposure to a NMDA ago-
nist by promoting expression of nerve growth factor (Carlson
et al., 1999). Furthermore, other studies indicated that IL-R1 sig-
naling is critical to establish the protective effects of tolerance
induced by a variety of preconditioning regimen on excitotoxicty-
associated neuronal damage (Ohtsuki et al., 1996; Durukan and
Tatlisumak, 2010; Mayado et al., 2011). Finally, the role of IL-1
cytokines could be bi-phasic, with dosage and timing parame-
ters being critically implicated (Bernardino et al., 2005; Hayakawa
et al., 2010). Indeed, whereas pre-incubation of organotypic hip-
pocampal slices with a relatively low dose of recombinant IL-1β
enhanced AMPA-induced neuronal toxicity, a higher dose of
IL-1β protected neurons (Bernardino et al., 2005). In light of these
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observations, the overall impact of IL-1 cytokines in mediating
neuronal survival or death appears to be context dependent.
Whereas a relatively elevated level of IL-1 signaling before the
initiation of an excitotoxic insult stimulates the induction of
tolerance in neurons, post-insult signaling seems to favor a detri-
mental outcome on neuronal homeostasis.
Interestingly, a recent study suggested that post-lesion IL-1 sig-
naling mediated by IL-1RAcPb (AcPb) could provide significant
neuroprotection (Smith et al., 2009). AcPb is an isoform of AcP
derived from an alternative splicing of exon 12 in the C-terminal
that is only 35% similar to that of AcP, and yields a mature protein
that possesses 140 additional amino acids in its C-terminal (Smith
et al., 2009). Interestingly, AcPb expression is restricted to neu-
rons. Though both proteins modulate MAP kinases activity and
in particular the p38 pathway, AcPb, unlike AcP, does not acti-
vate canonical NF-κB transcription factors (Huang et al., 2011;
Nguyen et al., 2011). Consequently, AcPb signaling has relatively
marginal effects of gene transcription compared to AcP. However,
AcPb activity enhances calcium influx following N-Methyl-D-
aspartic acid (NMDA)-induced stimulations by modulating Src
phosphorylation (Huang et al., 2011). Thus, it appears to tune
synaptic and neuronal activities. Interestingly, mice deficient for
AcPb exhibited more neuronal damage than WT mice following
an intracerebral injection of the potent pro-inflammatory toll-like
receptor 4 ligand lipopolysaccharide (LPS) (Smith et al., 2009).
These latter properties of AcPb are quite interesting as they
suggest that AcPb could modulate calcium signaling and thus
regulate the ability of neurons to cope with aberrant cal-
cium regulations, as they occur for example with excitotoxic
insults. Therefore, the present study tested the hypothesis that
AcPb signaling modulates neuronal survival during excitotoxic
insults induced by an injection of kainic acid (KA). KA is a
potent agonist of the ionotropic glutaminergic receptors Kainate
and AMPA (Wang et al., 2005). Intracerebral injection of KA
causes excessive neuronal influx of Ca2+, oxidative stress, and
mitochondrial dysfunctions leading to neuronal death through
multiple mechanisms of necrosis and apoptosis (Zheng et al.,
2011). Using mice deficient for AcPb, we demonstrate that
AcPb signaling confers cortical neurons significant long-term
protection against the excitototoxic effects of an intracerebral
injection of KA.
MATERIALS ANDMETHODS
ANIMALS
Adult male C57BL/6J mice were purchased at 7–8 weeks of age
from Taconic. Male IL-1RAcPb-deficient mice (AcPb−/−), on a
C57Bl/6J background, were generated as previously described and
then bred in-house (Smith et al., 2009). All animals (25–30 g)
were acclimated to standard laboratory conditions (14 h light,
10 h dark cycle; lights on at 06:00 and off at 20:00 h) with free
access to rodent chow and water. All protocols were conducted
according to the Canadian Council on Animal Care guidelines, as
administered by the Laval University Animal Welfare Committee.
KAINIC ACID STEREOTAXIC INJECTION
Mice were anesthetized with isofluorane, and the site of injection
was stereotaxically reached (David Kopf Instruments, Tujunga,
CA). The coordinates from bregma were 0.0mm anterior-
posterior, −2.0mm lateral and −3.2mm dorsoventral in order
to reach the right striatum, as identified in the mouse brain
atlas Paxinos and Franklin (2001). A volume of 2.0μl contain-
ing 150 ng of KA (Sigma) diluted in vehicle (sterile 0.9% saline)
was infused over 2min by means of a 28-gauge stainless steel
cannula (Plastics One, Roanoke, VA) that was connected to a
50μl Hamilton syringe mounted on a UltraMicroPump II con-
trolled by microprocessor controller Micro4 (World Precision
Instruments). Control mice were injected with 2.0μl of vehicle.
A 2min rest was allowed after the injections, and the syringe was
then raised incrementally over a period of 2min. Mice received
1.0ml of saline subcutaneously after the injection, and were
housed one per cage until sacrifice.
PERFUSION AND TISSUE PREPARATION
Mice were anesthetized at different time points (12 h, 48 h, and
15 days post injection) with an intraperitoneal injection (100μl)
of ketamine hydrochloride (91mg/ml) and xylazine (9.1mg/ml)
and then rapidly perfused transcardially with 0.9% saline, fol-
lowed by 4% paraformaldehyde (PFA) either in 0.1M borax
buffer, pH 9.0 at 4◦C. After perfusion, brains were rapidly
removed from the skulls, postfixed for 4 days, and then placed in
a solution containing 20% sucrose diluted in 4% PFA/3.8% borax
buffer (pH 9.0). The frozen brains were mounted on a microtome
(Reichert–Jung, Cambridge Instruments, Deerfield, IL), frozen
with dry ice, and cut into 25-μmcoronal sections from the start of
the prefrontal cortex to the end of the cerebral cortex. The slices
were collected in a cold cryoprotective solution (0.05M sodium
phosphate buffer, pH 7.3, 30% ethylene glycol, 20% glycerol) and
stored at −20◦C.
In situ HYBRIDIZATION (ISH) AND IMMUNOHISTOCHEMISTRY (IHC)
Standard ISH was performed on every 12th coronal section of
the entire rostro-caudal extent of each brain using 35S-labeled
cRNA probes as described previously (Laflamme and Rivest,
1999; Laflamme et al., 2003). See Table 1 for the list of cRNA
probes used. Some sections were processed for double-label IHC
and ISH, using an antibody directed against the neuronal nuclei
marker NeuN (BD Pharmingen) and a 35S-labeled Atf3, Bdnf,
or calpastatin cRNA probes. Slices were first washed in ster-
ile DEPC-treated 50mM potassium phosphate-buffered saline
(KPBS) and then incubated for 2 h at room temperature with
NeuN (1:1000) antibody (Millipore) diluted in sterile KPBS plus
0.2% Triton X-100, 0.5% BSA (fraction V; Sigma-Aldrich) and
0.25% heparin sodium salt USP. Brain slices were then rinsed in
sterile KPBS and appropriately incubated with a solution of Triton
X-100, 0.5% BSA, 0.25% heparin sodium salt and biotinylated
goat anti-rat IgG (1:500) or biotinylated goat anti-rabbit (1:1000)
secondary antibody at room temperature for 2 h. Sections were
then rinsed with KPBS and incubated at room temperature for
60min with an avidin-biotin-peroxidase complex (Vectastin ABC
Elite kit; Vector Laboratories), after which they were washed
again in sterile KPBS. A solution of chromogen 3,3′-diamino-
benzidine tetrahydrochloride (0.05%) and 0.003% H2O2 diluted
in KPBS was applied to the brain slices and the ensuing peroxidase
reaction was allowed to proceed for 10min. Sections were then
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Table 1 | Plasmids and enzymes used for the synthesis of the cRNA probes.
Plasmid Vector Lenght
(bp)
Enzymes used for
antisense probe
Source
Mouse Atf3 PCRII-Topo 1430 Xbal/Sp6 Cloning: 5′ Primer ctg ggt cac tgg tat ttg agg att; 3′ aca
aaa gtg cca tta aca tcc cac
Mouse Bdnf PCRII-Topo 684 Spel T7 Dr. Steve Lacroix, Laval University; Cloning: 5′ Primer tac
ctt cct gca tct gtt gg; 3′ cag cct tcc ttg gtg taa cc
Mouse Cast
(calpastatin)
PCRII-Topo 1730 Xbal/Sp6 Cloning: 5′ Primer gcg gag caa gtc agg gtt gtc; 3′ atg tt
gcc gga ctg
Mouse
Fox03a
PCRII-Topo 839 Xhol/Sp6 Cloning: 5′ Primer ggc acc atg aat ctg aat gat g; 3′ acc aac
aac gtt ctg tgt gga g
Mouse II1a PCR blunt II 1985 Xhol/Sp6 Dr. P. W. Gray, Genetech Inc. San Francisco, CA, USA
(Lomedico et al., 1984)
Mouse IIlb PCR blunt II 1360 Kpn1/T7 Dr. P. W. Gray, Genetech Inc. San Francisco, CA, USA
(Gray et al., 1986)
rinsed in KPBS, mounted onto Fisherbrand Colorfrost micro-
scope slides, and underwent the in situ hybridization histochem-
istry described above using Atf3, Bdnf, or calpastatin 35S-labeled
cRNA probe. Ethanol-dehydrating steps were shortened to 3–4
dips to minimize IHC signal loss.
In situ HYBRIDIZATION ANALYSES
In situ hydridization signals were measured on Biomax MR x-ray
films (Kodak, Rochester, NY) using a Northern Light desktop illu-
minator (Imaging Research, Ste-Catherine’s, Ontario, Canada)
and a Sony (Tokyo, Japan) camera video system attached to
a MicroNikkor 55mm Vivitar extension tube set for a Nikon
(Montreal, Quebec, Canada) lens and coupled to a Dimension
GX270 personal computer (Dell Computer, North York, Ontario,
Canada) and ImageJ software (version 1.23;W. Rasband, National
Institute of Health, Bethesda, MD). The optical density (O.D.) for
each pixel was calculated using a known standard of intensity and
distance measurements from a logarithmic specter adapted from
BioImage Visage 110s (Millipore, Ann Arbor, MI). Analyses for
in situ hybridization signals were performed in the deeper half
of the dorsolateral cortex, bilaterally, as illustrated in Figure 2C.
Data for each mice consisted in the average O.D. signals from two
separate slices located between bregma−0.82mm and−1.58mm
on the anterior-posterior axis, and data for one slice consisted in
the average O.D. of the values of the right and left hemispheres.
Each value for a hemisphere was corrected for background signal
by subtracting from it the O.D. value taken at a brain area devoid
of positive signal.
FLUORO-JADE B STAINING
Every 12th section was mounted on Colorfrost/Plus microscope
slides (Fisher Scientific, Pittsburgh, PA). The Fluoro-Jade B (FJB)
staining procedure was employed to reveal neuronal death as
described previously (Turrin and Rivest, 2006). Briefly, dried
mounted brain sections were first fixed with 4% PFA vapors in
a closed container placed in a water bath heated at 37◦C for
2.5 h. The 4% PFA, in liquid form, was only present at the bot-
tom of the container to not have the slides submerged. Slides
were then let to air-dry and were dehydrated and rehydrated
through graded concentrations of alcohol (50, 70, 100, 70, and
50% EtOH, 1min each), and rinsed for 1min in distilled water.
Slides were then treated with potassium permanganate (0.06%)
for 10min and rinsed for 1min in distilled water, followed
by 0.004% FJB (Histochem, Jefferson, AR) in 0.1% acetic acid
and 0.0002% 4′,6-diamidino-2-phenylindole (DAPI; Invitrogen,
Burlington, ON, Canada) for 20min. Slides were thereafter rinsed
in distilled water (3 × 1min), dried overnight at 37◦C, dipped
in xylene (3 × 2min), and then coverslipped with distrene plas-
ticizer xylene (DPX) mounting media (Electron Microscopy
Sciences, Washington, PA).
FLUORO-JADE B QUANTIFICATION
Visualization of FJB-positive regions from the slides was done by
using a C-80 Nikon microscope and super-high-pressure mer-
cury lamp (Nikon) fitted with a Retiga EXi Fast digital camera
(QImaging, Burnaby, BC, Canada) connected to a Precision 660
workstation (Dell Computer). As illustrated in Figure 2C, the
bilateral deeper halves of the dorsolateral cortex were traced on
a Wacom pen tablet (Vancouver, WA) by using the Neurolucida
stereological software package (version 6.02.1; MicroBrightField,
Williston, VT). The FJB-positive cells were then counted in the
deeper half of the dorsolateral cortex, bilaterally, over two sepa-
rate slices located between bregma −0.82mm and −1.58mm on
the anterior-posterior axis. Data for each mice consisted in the
average density of FJB-positive cell over the two slices.
STATISTICAL ANALYSES
Data are expressed as mean ± standard error. Statistical analyses
were performed with Two-Way ANOVA followed by Bonferroni
post hoc test using Graph Pad Prism v5.0 software. Alpha level was
set at 0.05.
RESULTS
KAINIC ACID INJECTION CAUSES De novo SYNTHESIS OF IL-1ALPHA
AND IL-1BETA TRANSCRIPTS IN THE BRAIN
Within 1 h after an intrastriatal injection of KA, mice developed
significant convulsions, consisting in tremors, head-noddings and
loss of balance.Mice displayed great variability however in the fre-
quency and intensity with which they exhibited these signs, rang-
ing from verymild to very strong displays of convulsive behaviors.
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In most cases, these signs largely disappeared by the start of the
second day post-injection (i.e., after 24–36 h), although some still
displayed subtle convulsive behaviors until the end of the third
day. Finally, none of the mice that received the vehicle injection
demonstrated any signs of convulsion.
The convulsive behaviors of mice that received KA suggested
that KA induced a strong dysregulation of neuronal activity, likely
implicating excitotoxicity. As a large body of evidence suggests
that KA-induced excitotoxicity is accompanied by an increase
in the expression of numerous pro-inflammatory cytokines, we
sought to confirm that cytokines IL-1α and IL-1β are de novo
synthesized. Increased expression of IL-1α mRNA was detected
at 12 and 48 h post-injection in the brain of mice that received
KA, and was particularly strong in the cortex compared to other
brain areas (Figure 1A). A clear upregulation of IL-1β mRNA
at 12 h post-injection was also detected throughout the brain,
including cortical and thalamic brain regions (Figure 1B). In con-
trast to IL-1α, IL-1β mRNA expression decreased dramatically
at 48 h post-injection, suggesting that the expression of these
cytokines is regulated by different mechanisms. Finally, expres-
sion for either cytokines remained undetectable in mice injected
with vehicle. Overall, these data confirm that an intrastriatal
injection of KA causes a strong induction of IL-1α and IL-1β
cytokines in the brain, albeit with different kinetics. This suggests
that these cytokines may play a role in modulating and coordinat-
ing the neuronal and inflammatory activities that are associated
with KA-mediated excitotoxic insults.
EXCITOTOXICITY MODULATES SIMILARLY GENE EXPRESSION OF
TRANSCRIPTION FACTORS Atf3 AND FoxO3a IN WT AND
AcPb-DEFICIENT MICE
Multiple mechanisms are activated in neurons to help them
cope with the metabolic and oxidative stresses that develop fol-
lowing their dysregulated and excessive firings triggered by KA.
Previous research showed that the activity of activating transcrip-
tion factor 3 (Atf3) confers neuroprotective effects in contexts
of calcium-mediated excitotoxicity (Francis et al., 2004; Zhang
et al., 2009, 2011). As depicted by the Figure 2A, a strong induc-
tion of Atf3 mRNA is detected in the brain of mice that received
KA, but not in mice that received vehicle. However, the spa-
tial pattern of Atf3 expression was quite variable among the
mice, possibly reflecting intrinsic differences in vulnerability and
susceptibility to KA-induced excitotoxicity. Atf3 induction was
strongest at 12 h post-injection, and returned to basal levels by
48 h (data not shown), which paralleled the temporal pattern
of convulsive behaviors. Furthermore, colocalization experiments
with neuronal maker NeuN indicated that Atf3 mRNA upregu-
lation occurred exclusively in neurons (Figure 2B). Interestingly,
the initial study by Smith et al. (2009) that reported the dis-
covery of AcPb also provided evidence that this adaptor protein
can modulate transcription of Atf3 in response to IL-1β (Smith
et al., 2009). Thus, we tested the hypothesis that the increased
transcription of the Atf3 gene is regulated by signaling effec-
tors downstream of AcPb. To test this hypothesis, we measured
by optical densitometry Atf3 transcript levels within the deeper
half of the cerebral cortex, bilaterally (Figure 2C). This brain
region was selected because it showed a consistent pattern of
FIGURE 1 | Unilateral intrastriatal injection of kainic acid (KA) induces
transcription of pro-inflammatory cytokines interleukin 1 alpha (IL-1α)
and beta (IL-1β) throughout the brain. (A and B) As depicted by dark-field
photomicrographs, excitotoxicity triggered by intrastriatal injection of KA
causes a strong induction of (A) IL-1α and (B) IL-1β gene transcription.
mRNAs for these cytokines are clearly detected in numerous brain regions,
including cortical and thalamic areas, at 12 and 48 h post-injection. No
mRNA upregulation for these cytokines was detected in mice that received
vehicle solution. Scale bars: 200μm.
expression across all the mice that received KA. However, no sig-
nificant differences in Atf3 mRNA expression between WT and
AcPb−/− mice were noted at 12 h post injection (Figure 2D). This
result suggests that in a complex in vivo setting, AcPb signaling
has little, if any, impact on the induction of transcription of the
Atf3 gene.
Another signaling system implicated in neuroprotection dur-
ing excitotoxicity involves the transcription factor forkhead box
O3a (FoxO3a) (Mojsilovic-Petrovic et al., 2009; Dick and Bading,
2010). We thus investigated whether its expression is modulated
during excitotoxicity. Interestingly, within the same areas of the
cortex that exhibited a strong Atf3 mRNA induction, we found a
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FIGURE 2 | IL-1RAcPb signaling does not modulate induction of Atf3
transcription factor mRNA in neurons following kainic acid (KA)
injection. (A and D) Intrastriatal injection of KA, but not vehicle injection,
triggered bilaterally a profound increase in Atf3 mRNA in the deep layers of
the dorsolateral cortex 12 h post-injection. This increase was similar in WT
and AcPb-deficient mice. (A) Representative dark-field photomicrographs of
dipped NTB2 emulsion. (B) Combination of in situ hybridization targeting
Atf3 mRNA with immunohistochemistry (IHC) using NeuN antisera to label
neurons revealed that Atf3 mRNA is upregulated in neurons. White
arrowhead, positive co-localization. Scale bars: 100μm. (C) Differential optical
density analyses for Atf3 in situ hybridization signals were performed in the
deeper half of the dorsolateral cortex, bilaterally. Note that all subsequent
analyses were conducted in these same areas. (D) Optical density (O.D., in
arbitrary units) of hybridization signal in the deep layers of the dorsolateral
cortex 12 h post-injection, as described in “Materials and Methods.” Data are
means ± SEM (bars) values from 3 to 8 mice per group. Significant
differences were established by Two-Way ANOVA followed by Bonferroni
post hoc test. ∗∗p < 0.01.
decrease in the expression of the FoxO3a transcript at both 12 and
48 h post-injection (Figures 3A,B, andC). However, this decrease
was essentially similar in WT and AcPb−/− mice. Thus, FoxO3a
is not modulated at the transcriptional level by AcPb signaling.
Overall, these results suggest that in a context of excitotoxicity,
signaling downstream of AcPb does not regulate the mechanisms
implicated in the expression of transcription factors Atf3 and
FoxO3a that are relevant to the modulation of neuronal survival.
NO SIGNIFICANT DIFFERENCE IN Bdnf mRNA TRANSCRIPTION INWT
COMPARED TO AcPb−/− MICE
An intimate relationship exists between synaptic activity and neu-
rotrophin brain-derived neurotrophic factor (Bdnf), in which
both mutually regulate the activity of each other (Poo, 2001;
Greenberg et al., 2009; Pozo and Goda, 2010). Indeed, Ca2+-
dependent mechanisms modulate positively the release of Bdnf,
which in turn modulates signaling pathways involved in synap-
tic plasticity (Pozo and Goda, 2010). Bdnf signaling has
frequently been associated with neuroprotection following exci-
totoxic insults (Glazner and Mattson, 2000; Gratacos et al., 2001;
Almeida et al., 2005; Gobbo and O’Mara, 2005; Jiang et al., 2005;
Bemelmans et al., 2006; Bovolenta et al., 2010; Vidaurre et al.,
2012). Also of interest, IL-1β may interfere with Bdnf signaling
in neurons (Tong et al., 2008). Thus, we investigated the possi-
bility that IL-1 signaling through AcPb modulates Bdnf mRNA
transcription by assessing the expression level of the Bdnf tran-
script in the deeper half of the cortex, bilaterally. KA injection
caused a very strong increase in the transcription of the Bdnf gene
in cortical neurons at 12 h post-injection, and this increase was
similar in WT and AcPb-deficient mice (Figures 4A,B,D, and E).
At 48 h, Bdnf mRNA levels decreased compared to 12 h, but were
still elevated compared to vehicle-injected mice (Figure 4C). Note
also that to the extent that Bdnf mRNA synthesis is indicative of
synaptic activity, these data suggest that the initial early response
to KA is similar in WT and AcPb-deficient mice.
AcPb SIGNALING PROMOTES A DELAYED TRANSCRIPTION OF
CALPASTATIN DURING EXCITOTOXIC INSULTS
Numerous lines of evidence suggest a significant implication of
the calpain-calpastatin system in neuronal excitotoxic pathologies
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FIGURE 3 | Decrease of FoxO3a mRNA in the deep layers of the
dorsolateral cortex in WT and AcPb-deficient mice following intrastriatal
injection of kainic acid (KA). (A) Dark-field photomicrographs of dipped
NTB2 emulsion slides showing expression of Foxo3a mRNA at 12 and 48h
post-injection of KA. (B and C) Differential optical density (O.D., in arbitrary
units) of hybridization signal in the bilateral deep layers of the dorsolateral
cortex at (B) 12 and (C) 48h post-injection, as described in “Materials and
Methods.” Data are means ± SEM (bars) values from 3 to 5 mice per group.
Significant differences were established by Two-Way ANOVA followed by
Bonferroni post hoc test. ∗p < 0.05, ∗∗p < 0.01.
(Wu et al., 2004; Higuchi et al., 2005, 2012; Takano et al., 2005;
Araujo et al., 2007, 2008; Cao et al., 2007). Calpains are cysteine
proteases and are important effectors of neuronal damage dur-
ing ischemia, oxygen-glucose deprivation, and NMDA-induced
neuronal death (Cao et al., 2007; Bevers et al., 2009, 2010).
Importantly however, the activity of neuronal calpains is inhibited
by calpastatin, and this protein confers significant neuroprotec-
tion in models implicating excitotoxicity (Higuchi et al., 2005;
Takano et al., 2005). We thus examined whether KA-induced
excitotoxicity is associated with changes in calpastatin gene tran-
scription, and whether those changes are modulated by AcPb
signaling. As can be seen on Figure 5, a bi-phasic modulation of
calpastatin mRNA expression level occurred in cortical neurons
following KA injection. Indeed, 12 h following KA injection, cal-
pastatin mRNA levels decreased similarly in WT and AcPb−/−
mice (Figures 5A and B). However, at 48 h post-injection, cal-
pastatin mRNA levels recovered (Figures 5A and C). At that
time, WT mice that received KA actually displayed a strong
trend towards an increased expression compared to vehicle-
treated mice, although this effect was not statistically significant
(Figures 5A and C). Interestingly, this recovery and possible
enhancement are dependent on signaling events downstream of
AcPb, as calpastatin mRNA expression at 48 h in AcPb-deficient
mice was significantly lower than that of WT. Calpastatin mRNA
levels in AcPb−/− mice remained 17% lower than those of mice
that received vehicle at 48 h. These results therefore suggest that
AcPb signaling provides an important positive regulatory input
in the modulation of a key mechanism of neuroprotection against
KA-induced excitotoxicity.
AcPb SIGNALING DURING EXCITOTOXIC INSULTS PROMOTES
LONG-TERM NEURONAL SURVIVAL.
The significant increase in calpastatin mRNA expression in WT
compared to AcPb−/− mice, combined with the strong trends
toward higher levels of Bdnf transcripts in WT mice at 48 h,
suggest that signaling events downstream of AcPb could confer
neurons with significant protection against calcium-related dis-
ease mechanisms and thus promote neuronal survival in a context
of excitotoxicity. We examined this possibility by quantifying neu-
ronal damage marker FJB-positive signal/cells in the deeper half
of the cerebral cortex, bilaterally. Injection of KA, but not vehicle,
led to significant neuronal damage, as depicted by the presence of
numerous FJB-positive cells (Figure 6). Extensive damage already
had occurred by 12 h post-injection and it further increased at
48 h. However, quantification of FJB cells did not reveal any dif-
ferences between WT and AcPb−/− mice at either 12 or 48 h
(Figures 6A,B and C). Although this was not consistent with
our initial prediction, we reasoned that these time points may
have been too early to assess the possible beneficial effects of the
increased expression of calpastatin that had just begun to pro-
ceed. To address this issue, we conducted another experiment in
which mice were allowed to survive for 15 days after the injection
of KA. Interestingly, WT mice at that time displayed significantly
less FJB-positive cells in the deeper half of the cerebral cortex than
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FIGURE 4 | Similar induction of neuronal Bdnf mRNA expression in
WT and AcPb-deficient mice in response to excitotoxicity triggered
by an intrastriatal injection of kainic acid (KA). (A) Representative
dark-field photomicrographs of dipped NTB2 emulsion slides showing
expression of Bdnf mRNA at 12 and 48 h post-injection of KA. (B and C)
Differential optical density (O.D., in arbitrary units) of hybridization signal
in the bilateral deep layers of the dorsolateral cortex at (B) 12 and (C)
48h post-injection, as described in “Materials and Methods.” Data are
means ± SEM (bars) values from 3 to 8 mice per group. Significant
differences were established by Two-Way ANOVA followed by Bonferroni
post hoc test. (D and E) Neuronal expression of Bdnf mRNA was
confirmed by combining in situ hybridization with immunohistochemistry
using antisera directed against NeuN. White arrowhead, positive
co-localization. Scale bars: (D) 100μm, (E) 10μm. ∗p < 0.05, ∗∗p < 0.01.
AcPb−/− mice (Figures 6A and D). This suggests that AcPb sig-
naling regulates adaptive mechanisms in neurons that contribute
substantially to their long-term protection following excitotoxic
insults.
DISCUSSION
A wide range of different types of excitotoxic lesions and exces-
sive dysregulations of calcium homeostasis are intrinsically linked
to neurodegenerative diseases. In response to these insults, IL-1
cytokines are secreted to stimulate the activity of the innate
immune system and to adapt the cellular activity of neighbor-
ing cells to prevent spread of damage and to eventually promote
brain repair. We provide here evidence that a neuron-specific IL-1
signaling pathway downstream of adaptor protein IL-1RAcPb
may enhance the ability of cortical neurons to cope and survive
excessive calcium influx and/or the strong oxidative stress that
accompanies an acute inflammatory response. Indeed, signaling
through AcPb in neurons promoted a delayed transcription of
calpastatin, which in turn could presumably inhibit the pro-death
activities of calpains. This observation not only confirms the neu-
roprotective properties of AcPb signaling, as originally reported
by Smith et al. (2009), but it also expands upon it by identi-
fying a potential mechanism accounting for its neuroprotective
effects. This study also further highlights the intimate link that
exists between AcPb and the regulation of calcium signaling in
neurons recently suggested by Huang and colleagues (2011).
The inhibitory properties of calpastatin on the activity of
the calpain proteases are very potent. Calpastatin has a very
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FIGURE 5 | AcPb signaling is necessary for the delayed increase of
transcription of the calpastatin gene in cortical neurons following
intrastriatal injection of kainic acid (KA). (A) Representative dark-field
photomicrographs of dipped NTB2 emulsion slides showing bi-phasic
expression of calpastatin mRNA at 12 and 48 h post-injection of KA. (B and C)
Differential optical density (O.D., in arbitrary units) of hybridization signal in
the bilateral deep layers of the dorsolateral cortex at (B) 12 and (C) 48 h
post-injection, as described in “Materials and Methods.” Data are means ±
SEM (bars) values from 3 to 8 mice per group. Significant differences were
established by Two-Way ANOVA followed by Bonferroni post hoc test.
(D and E) Neuronal expression of calpastatin mRNA was confirmed by
combining in situ hybridization with immunohistochemistry using antisera
directed against NeuN. White arrowhead, positive co-localization. Scale bars:
(D) 100μm, (E) 10μm. ∗∗p < 0.01.
high binding affinity for both μ- and m-calpains in the pres-
ence of calcium, and one calpastatin molecule can inhibit up
to four calpain molecules (Maki et al., 1988). Many studies
have revealed a major neuroprotective role for calpastatin in a
variety of brain lesions involving excitotoxicity. For example, cal-
pastatin deficiency in mice increased neuronal death following
intra-hippocampal injections of KA (Takano et al., 2005). In
contrast, neurons of transgenic mice overexpressing calpastatin
exhibited an enhanced resistance to excitotoxicity-induced death
(Higuchi et al., 2005; Takano et al., 2005). Furthermore, a study
recently reported that calpastatin is neuroprotective in a model
of excitotoxic-related apoptosis, but not during excitotoxicity-
related necrosis (D’Orsi et al., 2012). Our data seem to be in
agreement with this latter observation, as we found a protective
effect for AcPb signaling at 15 days post-injection, but not at 12
or 48 h. Note however that the exact mechanism by which AcPb
signaling promotes transcription of calpastatin remains to be elu-
cidated. Evidence suggests that the activation of Src kinases by
AcPb, as reported by Huang et al. (2011), could be a key fac-
tor. Indeed, Src in neurons can regulate the PI3K-Akt signaling
pathway, which in turn controls cAMP response element-binding
protein (CREB) (Crossthwaite et al., 2004). Interestingly, CREB
promotes transcription of the calpastatin gene (Arroba et al.,
2009).
The present study suggests that there is a context-specificity
within the spectrum of excitotoxic lesions in which AcPb
signaling confers neuroprotection. Although no electrophysiolog-
ical analyses were performed, we found no evidence that lack of
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FIGURE 6 | AcPb promotes long-term survival of cortical neurons
following induction of excitotoxicity by intrastriatal injection of
kainic acid (KA). (A) Representative photomicrographs of fluoro-jade B
(FJB) staining revealing neuronal death at 12 and 48h, and 15 days
post-injection of KA. (B–D). Stereological quantification of FJB-positive
cells in the bilateral deep layers of the dorsolateral cortex at (B) 12 h,
(C) 48 h, and 15 days post-injection (D). Data are means ± SEM (bars)
values from 3 to 8 mice per group. Significant differences were
established by Two-Way ANOVA followed by Bonferroni post hoc test.
Scale bar: 1.0mm. ∗p < 0.05, ∗∗p < 0.01.
AcPb abrogated the initial response of neurons to KA in mice,
as expression of Atf3, FoxO3a, Bdnf, and calpastatin mRNAs at
12 h, and FJB counts at 12 and 48 h, were similar in WT and
AcPb−/− mice. Note that it is possible that the high concen-
tration of KA in the cerebral milieu shortly after the injection
may have masked the effects of a regulatory role of AcPb on
neuronal activity at the early time point. However, over time
the excitotoxic insults evolve and the sustained stimulation of
neuronal circuitries necessarily becomes more dependent on
endogenous, more physiological concentrations of glutamate and
Ca2+. As this occurs, reorganization of intracellular signaling and
metabolic pathways may proceed to allow surviving neurons to
deal with prolonged Ca2+, metabolic, and oxidative stresses. This
is the pathophysiological context in which AcPb signaling may
contribute significantly to neuroprotection. Indeed, AcPb could
provide substantial regulatory activity on the establishment of a
neuroprotective, calpastatin-dependentmechanism that increases
the resistance of neurons to chronic, high glutaminergic excita-
tions and sustained elevated influx of Ca2+. Our results show-
ing that a higher, delayed expression of calpastatin mRNA in
WT mice compared to AcPb-deficient mice 48 h after KA injec-
tion is accompanied by a lower level of neuronal damage, as
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measured by FJB at day 15 post-injection, support this pos-
sibility. Importantly, these results are consistent with a study
by Stifanese et al. (2010) that also provided evidence that
adaptive changes within the calpain-calpastatin system, includ-
ing an induction of calpastatin transcription, might be key
to allow neurons to cope with prolonged elevated intracel-
lular levels Ca2+ (Stifanese et al., 2010). Note however that
the magnitude of the excitotoxic lesion may be a determin-
ing factor as to whether upregulation of calpastatin gene tran-
scription through endogenous signaling pathways can proceed
and provide a neuroprotective effect, as we found no evidence
that this gene is modulated in the brain of APPPS1/SWE mice
despite the presence of senile plaques (Laflamme, Rivest, unpub-
lished observation).
On a more general note, the present study is among the
first to provide in vivo evidence for an intrinsic neuronal pro-
tective mechanism modulated by IL-1 signaling. Indeed, most
studies investigating the effects of IL-1 cytokines initiated as a
consequence of excitotoxic insults have typically observed a detri-
mental outcome on neuronal survival for IL-1 signaling. It is
worth noting however that those studies that investigated the
role of IL-1 cytokines in such settings have used experimental
paradigms involving the complete inhibition of their activities,
either by injecting recombinant IL-1RA, or using mice deficient
for the different components of IL-1 signaling (i.e., Relton and
Rothwell, 1992; Vezzani et al., 2000). Such paradigms could hardly
dissociate the effects of IL-1 signaling in promoting the acute
inflammatory response from those more specifically involved in
the regulation of signaling pathways that allow neurons to cope
with excessive glutaminergic and calcium stimulations. In fact,
the role of IL-1 cytokines in modulating cellular responses in
a cell-specific manner, in vivo, has actually received little atten-
tion to this day, and significant neuroprotective mechanisms may
thus have been overshadowed. In addition, our results also sug-
gest that it may be valuable to precisely examine the role of IL-1
signaling during excitotoxic insults in a cell-type specific manner
by using conditional knockout mice models. This strategy could
prove to be quite helpful in determining whether the overall net
effect of IL-1 signaling is typically associated with a detrimen-
tal outcome for neurons because it promotes an overwhelming
inflammatory response or because it negatively affects the intrin-
sic ability of neurons to adapt and survive excitotoxicity-related
damage.
In sum, this study suggests that during acute excitotoxic
insults, IL-1RAcPb signaling in neurons promotes a delayed tran-
scription of calpastatin, which in turn could provide substantial
protection to neurons from the long-term damaging and toxic
effects of excessive calcium stimulations. It will be critical to
determine in the future whether such adaptive mechanism also
plays a key role in the etiology and progression of more chronic
neurodegenerative diseases.
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